Avacta Group Future Growth
Future criteria checks 1/6
Avacta Group's earnings are forecast to decline at 3.5% per annum while its annual revenue is expected to grow at 11.1% per year. EPS is expected to grow by 7.1% per annum. Return on equity is forecast to be -63% in 3 years.
Key information
-3.5%
Earnings growth rate
7.1%
EPS growth rate
Biotechs earnings growth | 28.5% |
Revenue growth rate | 11.1% |
Future return on equity | -63.0% |
Analyst coverage | Low |
Last updated | 23 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 33 | -25 | -31 | N/A | 2 |
12/31/2025 | 28 | -34 | -33 | -24 | 3 |
12/31/2024 | 25 | -35 | -36 | -24 | 3 |
12/31/2023 | 23 | -25 | -16 | -15 | N/A |
9/30/2023 | 20 | -32 | -16 | -15 | N/A |
6/30/2023 | 16 | -42 | -16 | -15 | N/A |
3/31/2023 | 13 | -41 | -16 | -16 | N/A |
12/31/2022 | 10 | -37 | -17 | -16 | N/A |
9/30/2022 | 8 | -31 | -19 | -18 | N/A |
6/30/2022 | 7 | -25 | -21 | -20 | N/A |
3/31/2022 | 5 | -26 | -21 | -20 | N/A |
12/31/2021 | 3 | -26 | -22 | -21 | N/A |
6/30/2021 | 2 | -20 | -18 | -16 | N/A |
3/31/2021 | 2 | -18 | -15 | -14 | N/A |
12/31/2020 | 2 | -16 | -12 | -11 | N/A |
6/30/2020 | 5 | -12 | -9 | -8 | N/A |
3/31/2020 | 4 | -12 | -10 | -9 | N/A |
12/31/2019 | 4 | -11 | -11 | -9 | N/A |
7/31/2019 | 4 | -10 | -10 | -8 | N/A |
4/30/2019 | 3 | -10 | -9 | -6 | N/A |
1/31/2019 | 2 | -10 | -7 | -5 | N/A |
10/31/2018 | 3 | -9 | -8 | -5 | N/A |
7/31/2018 | 3 | -9 | -8 | -5 | N/A |
4/30/2018 | 3 | -8 | -8 | -6 | N/A |
1/31/2018 | 3 | -7 | -8 | -6 | N/A |
10/31/2017 | 3 | -7 | N/A | -5 | N/A |
7/31/2017 | 3 | -6 | N/A | -4 | N/A |
4/30/2017 | 3 | -6 | N/A | -4 | N/A |
1/31/2017 | 2 | -6 | N/A | -5 | N/A |
10/31/2016 | 2 | -5 | N/A | -4 | N/A |
7/31/2016 | 2 | -5 | N/A | -4 | N/A |
4/30/2016 | 2 | -5 | N/A | -3 | N/A |
1/31/2016 | 2 | -5 | N/A | -3 | N/A |
10/31/2015 | 2 | -5 | N/A | -3 | N/A |
7/31/2015 | 2 | -5 | N/A | -3 | N/A |
4/30/2015 | 2 | -4 | N/A | -2 | N/A |
1/31/2015 | 2 | -3 | N/A | -2 | N/A |
10/31/2014 | 2 | -2 | N/A | -1 | N/A |
7/31/2014 | 2 | -1 | N/A | -1 | N/A |
4/30/2014 | 2 | -1 | N/A | -1 | N/A |
1/31/2014 | 2 | -1 | N/A | -1 | N/A |
10/31/2013 | 3 | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AVCT.F is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AVCT.F is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AVCT.F is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AVCT.F's revenue (11.1% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: AVCT.F's revenue (11.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AVCT.F is forecast to be unprofitable in 3 years.